All News

Merck’s antibacterial drug injection—a combination of imipenem, cilastatin and relebactam (Recarbrio) —is indicated for adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).

A Bluetooth-enabled, nanochannel drug delivery system administers controlled doses based on patients’ therapeutic needs.

Top news of the day from across the health care landscape.

Acute flaccid myelitis (AFM) is a rare polio-like condition that can cause limb weakness, and it mostly occurs in young children.

Mergers and acquisitions among health care giants are causing massive disruption in specialty pharmacy.

Top news of the day from across the health care landscape.

Research highlights the importance of reaching non-white and younger populations with skin cancer prevention messages.

Data from the BEACON CRC trial show encorafenib, binimetinib, and cetuximab significantly improved overall survival in patients with BRAF-mutated metastatic colorectal cancer.

Acetaminophen-related overdose continues to be a leading cause of emergency deparment visits and hospitalizations and remains the leading cause of drug-induced acute liver failure in the United States.

Pre-symptomatic infants with spinal muscular atrophy treated with nusinersen showed continuous improvement in achieving motor milestones.

What caused this eye operation to have complications?

Top news of the day from across the health care landscape.

Which products on the market have the best data?

Pharmacists for Healthier Lives aims to raise awareness around the full range of health care services that pharmacists provide to consumers and patients.

Puma Biotechnology submitted a supplemental New Drug Application to the FDA for neratinib (Nerylnx) in combination with capecitabine for the treatment of patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Study finds elevated risk factors for cardiovascular disease in postmenopausal women with a history of breast cancer.

Top news of the week from Specialty Pharmacy Times.

Being effective may be the single most challenging tasks facing the pharmacy owner today.

New study demonstrates a novel approach of linking HER2-targeting antibodies with chemotherapy drugs for patients with breast cancer.

Direct and indirect remuneration (DIR) fees are imposed by pharmacy benefit managers (PBMs) on pharmacy providers after a drug claim has already been submitted, adjudicated, and even paid out to a pharmacy.

Top news of the day from across the health care landscape.

Research adds to a previously found correlation between yogurt consumption and a lowered risk of bowel cancer.

Patients with psoriasis reported frequent use of complementary and alternative treatments when their initial therapies did not help or had adverse effects.

Higher levels of selenium may benefit patients with compromised immune systems, such as patients with HIV, influenza, tuberculosis, or hepatitis C.

Fluoroquinolones are a commonly used antibiotic given its broad spectrum of activity. This class of antibiotics has an extensive safety profile that needs to be considered prior to initiating therapy.

State representatives shared successes, challenges, and lessons learned.

Videos of individuals licking ice cream and placing these cartons back on freezer store shelves have gone viral, and this practice can pose public health risks.

American Society of Health-System Pharmacists summer meeting included topics tied to the overarching themes of health system specialty pharmacy operations, clinical outcomes, and business development

Top news of the day from across the health care landscape.

Loren Kirk, director of Stakeholder Engagement for the Pharmacy Quality Alliance, speaks to Pharmacy Times on the findings of the Pharmacy-Provided Care Action Guide Report, during the Pharmacy Quality Alliance Annual Meeting.